Literature DB >> 3039042

Genome variations in herpes simplex virus type 2 strains isolated in Japan and Sweden.

H Sakaoka, T Kawana, L Grillner, T Aomori, T Yamaguchi, H Saito, K Fujinaga.   

Abstract

One-hundred and twenty-three epidemiologically unrelated strains of herpes simplex virus type 2 (HSV-2) isolated in Japan and Sweden (68 Japanese and 55 Swedish isolates) were compared by analysis of their genomes using five restriction endonucleases: BamHI, KpnI, EcoRI, HindIII and Bg/II. Seven of the 93 restriction sites examined showed statistically significant variation between isolates from the two countries. However, HSV-2 isolates were less variable than the HSV-1 isolates previously analysed from the same countries. Using 12 restriction sites as markers, the HSV-2 isolates were classified into 41 cleavage patterns; 17 were specific for Japanese isolates and 15 were specific for Swedish isolates. Correlation coefficients between some sets of 12 markers were significant, but significant correlations between Japanese and Swedish isolates were distinct for each country. Both Japanese and Swedish isolates were assigned to three major patterns with no significant difference in incidence. In contrast, in two other major patterns, differences in incidence between the isolates were statistically significant. These results suggest that HSV-2 populations in geographically separated countries have distinct cleavage site distributions.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3039042     DOI: 10.1099/0022-1317-68-8-2105

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  9 in total

1.  Discrimination of herpes simplex virus type 2 strains by nucleotide sequence variations.

Authors:  Hisatoshi Kaneko; Takashi Kawana; Ken Ishioka; Eiko Fukushima; Tatsuo Suzutani
Journal:  J Clin Microbiol       Date:  2007-12-12       Impact factor: 5.948

2.  Genomic, phylogenetic, and recombinational characterization of herpes simplex virus 2 strains.

Authors:  Aaron W Kolb; Inna V Larsen; Jacqueline A Cuellar; Curtis R Brandt
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

3.  Intratypic variation of herpes simplex virus type 2 isolates detected by monoclonal antibodies against viral glycoproteins.

Authors:  P Bhattarakosol; C Yoosook; A Cross
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

4.  Specific detection and identification of herpes B virus by a PCR-microplate hybridization assay.

Authors:  Chika Oya; Yoshitsugu Ochiai; Yojiro Taniuchi; Takashi Takano; Fukiko Ueda; Yasuhiro Yoshikawa; Ryo Hondo
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

5.  Type differentiation of herpes simplex virus by stringent hybridization of polymerase chain reaction products.

Authors:  S Inouye; R Hondo
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

6.  Viral genetic diversity and its potential contributions to the development and progression of neonatal herpes simplex virus (HSV) disease.

Authors:  Lisa N Akhtar; Moriah L Szpara
Journal:  Curr Clin Microbiol Rep       Date:  2019-11-23

7.  The herpevac trial for women: Sequence analysis of glycoproteins from viruses obtained from infected subjects.

Authors:  Miguel A Minaya; Maria Korom; Hong Wang; Robert B Belshe; Lynda A Morrison
Journal:  PLoS One       Date:  2017-04-27       Impact factor: 3.240

8.  Genotypic and Phenotypic Diversity of Herpes Simplex Virus 2 within the Infected Neonatal Population.

Authors:  Lisa N Akhtar; Christopher D Bowen; Daniel W Renner; Utsav Pandey; Ashley N Della Fera; David W Kimberlin; Mark N Prichard; Richard J Whitley; Matthew D Weitzman; Moriah L Szpara
Journal:  mSphere       Date:  2019-02-27       Impact factor: 4.389

9.  Evolution and diversity in human herpes simplex virus genomes.

Authors:  Moriah L Szpara; Derek Gatherer; Alejandro Ochoa; Benjamin Greenbaum; Aidan Dolan; Rory J Bowden; Lynn W Enquist; Matthieu Legendre; Andrew J Davison
Journal:  J Virol       Date:  2013-11-13       Impact factor: 5.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.